Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Visentin

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Pharmacology & Therapeutics|June 15, 2010
Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agentsMichele Visentin, Paola Biason, Giuseppe Toffoli
Cancer Chemotherapy and Pharmacology|April 8, 2015
Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosisRongbao Zhao, Michele Visentin, I David Goldman
Molecular Pharmacology|May 5, 2012
Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphateMichele Visentin, Rongbao Zhao, I David Goldman
Hematology/Oncology Clinics of North America|April 24, 2012
The antifolatesMichele Visentin, Rongbao Zhao, I David Goldman
Cancer Chemotherapy and Pharmacology|April 1, 2014
The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitroMichele Visentin, Ersin Selcuk Unal, I David Goldman
International Journal of Molecular Sciences|July 9, 2022
Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell GrowthGiovanna Azzarito, Michele Visentin, Brigitte Leeners, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 9, 2017
Drug-induced bile duct injuryMichele Visentin, Daniela Lenggenhager, Zhibo Gai, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2013
The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitorMichele Visentin, Ersin Selcuk Unal, Rongbao Zhao, et al.
Annual Review of Physiology|February 12, 2014
The intestinal absorption of folatesMichele Visentin, Ndeye Diop-Bove, Rongbao Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2019
Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2)Severin Hörmann, Zhibo Gai, Gerd A Kullak-Ublick, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Pharmacology & Therapeutics|June 15, 2010
Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agentsMichele Visentin, Paola Biason, Giuseppe Toffoli
Cancer Chemotherapy and Pharmacology|April 8, 2015
Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosisRongbao Zhao, Michele Visentin, I David Goldman
Molecular Pharmacology|May 5, 2012
Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphateMichele Visentin, Rongbao Zhao, I David Goldman
Hematology/Oncology Clinics of North America|April 24, 2012
The antifolatesMichele Visentin, Rongbao Zhao, I David Goldman
Cancer Chemotherapy and Pharmacology|April 1, 2014
The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitroMichele Visentin, Ersin Selcuk Unal, I David Goldman
International Journal of Molecular Sciences|July 9, 2022
Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell GrowthGiovanna Azzarito, Michele Visentin, Brigitte Leeners, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 9, 2017
Drug-induced bile duct injuryMichele Visentin, Daniela Lenggenhager, Zhibo Gai, et al.
Cancer Chemotherapy and Pharmacology|July 25, 2013
The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitorMichele Visentin, Ersin Selcuk Unal, Rongbao Zhao, et al.
Annual Review of Physiology|February 12, 2014
The intestinal absorption of folatesMichele Visentin, Ndeye Diop-Bove, Rongbao Zhao, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2019
Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2)Severin Hörmann, Zhibo Gai, Gerd A Kullak-Ublick, et al.
Pageof 6